$219.1
1.6%
Price vs. AI Score (Last 150 days)
Data gathered: December 1
Data gathered: December 1
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 1,250 -10.7% |
|
| Sentiment | 84 0% |
|
| Webpage traffic | 11,528,000 18.1% |
|
| Employee Rating | 73 0% |
|
| Google Adspend | $213,670 29% | N/A |
| Google Trends | 83 -7.8% |
|
| Linkedin Employees | 26,985 N/A |
|
| 4chan Mentions | 0% |
|
| Facebook Engagement | 162 -8.5% |
|
| Facebook followers | 12,964 0% |
|
| Stocktwits Mentions | 1 0% |
|
| Stocktwits Subscribers | 2,024 0% |
|
| Twitter Followers | 7,605 0% |
|
| Youtube Subscribers | 5,610 0% |
|
| Instagram Followers | 7,498 0.1% |
|
| News Mentions | 1 0% |
|
| Reddit Mentions | -100% |
|
| Business outlook | 65 0% |
|
In the news
Global Antibody Contract Manufacturing Market Report 2023 with Profiles of Leading Players AbbVie, Samsung Biologics, Aenova, Cambrex, Eurofins Scientific, AGC Biologics and MoreNovember 30 - GlobeNewswire |
|
Laboratory Corp. of America Holdings stock outperforms market on strong trading dayNovember 29 - MarketWatch |
|
 |
Smart or AI In-Vitro Diagnostics Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce AnalyticNovember 29 - PR Newswire UK |
Laboratory Corp. of America Holdings stock underperforms Tuesday when compared to competitorsNovember 27 - MarketWatch |
|
 |
Here's Why Investors Should Retain Labcorp (LH) Stock for NowNovember 26 - Yahoo |
Laboratory Corp. of America Holdings stock outperforms competitors on strong trading dayNovember 26 - MarketWatch |
|
About LabCorp
Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries.
| Price | $219.1 |
| Target Price | Sign up |
| Market Cap | $18.2B |
| Dividend Yield | 0.0135 |
| Industry | Health Care Services |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 3.06B | 2.21B | 851M | 183M | 344M |
| Q2 '23 | 3.03B | 2.19B | 842M | 189M | 340M |
| Q1 '23 | 3.78B | 2.8B | 975M | 213M | 406M |
| Q4 '22 | 3.67B | 2.7B | 970M | 76M | 171M |
| Q3 '22 | 2.87B | 1.98B | 886M | 353M | 542M |
Insider Transactions
| Wilkinson Peter J filed to sell 2,087 shares at $210.7. November 20 '23 |
| ANDERSON KERRII B filed to sell 15,275 shares at $211.6. August 10 '23 |
| Van Der Vaart Sandra D filed to sell 7,605 shares at $240. July 3 '23 |
| Schroeder Mark S filed to sell 6,687 shares at $216.8. May 22 '23 |
| Schroeder Mark S filed to sell 6,687 shares at $225.8. April 3 '23 |
Read more about LabCorp and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, instagram followers, news mentions, reddit mentions, business outlook.